After years of disappointing #malaria #vaccine trials, a malaria shot developed by researchers at the Jenner Institute at the University of Oxford has demonstrated an unprecedentedly high efficacy of 77 percent, and may be the magic bullet the world has been waiting for against the deadly disease. Watch the full video for more: https://buff.ly/3bshtwD | Xtalks Webinars
0:23
After years of disappointing #malaria #vaccine trials, a malaria shot developed by researchers at the Jenner Institute at the University of Oxford has demonstrated an unprecedentedly high efficacy of 77 percent, and may be the magic bullet the world has been waiting for against the deadly disease. Watch the full video for more: https://buff.ly/3bshtwD | Xtalks Webinars
8 viewsMay 16, 2021
FacebookXtalks Webinars
In this episode, hear about Intensity Therapeutics’ innovative intratumoral therapeutics, currently in trials for soft tissue sarcoma and breast cancer, from company founder, chairman and CEO Lewis Bender. Listen now at https://buff.ly/3Zxe7kd 🎙️ | Xtalks Webinars
0:48
In this episode, hear about Intensity Therapeutics’ innovative intratumoral therapeutics, currently in trials for soft tissue sarcoma and breast cancer, from company founder, chairman and CEO Lewis Bender. Listen now at https://buff.ly/3Zxe7kd 🎙️ | Xtalks Webinars
11 viewsDec 13, 2024
FacebookXtalks Webinars
The pharma and biotech industry has kicked off 2025 with some notable acquisitions after a relatively subdued 2024. Read more at https://buff.ly/4b9yV6M by Ayesha Rashid about the deals made so far and what to expect amid looming patent expirations and an uncertain regulatory environment. | Xtalks Webinars
0:30
The pharma and biotech industry has kicked off 2025 with some notable acquisitions after a relatively subdued 2024. Read more at https://buff.ly/4b9yV6M by Ayesha Rashid about the deals made so far and what to expect amid looming patent expirations and an uncertain regulatory environment. | Xtalks Webinars
9 viewsFeb 21, 2025
FacebookXtalks Webinars
In this episode, Dr. Robert Den, CMO at Alpha Tau Medical, discusses the company’s innovations in alpha radiation technology for cancer treatment. Discover their mission and impact on the field of radiation oncology. Listen now at https://buff.ly/3WmiJbX. | Xtalks Webinars
0:44
In this episode, Dr. Robert Den, CMO at Alpha Tau Medical, discusses the company’s innovations in alpha radiation technology for cancer treatment. Discover their mission and impact on the field of radiation oncology. Listen now at https://buff.ly/3WmiJbX. | Xtalks Webinars
6 viewsJan 16, 2025
FacebookXtalks Webinars
🛒🍎 The Good Food Prescription program from Good Measures combines expert clinical coaching, personalized meal planning and medically tailored grocery deliveries in partnership with Instacart. Read more to learn about the success of this program here: https://buff.ly/3OI5rTt | Xtalks Webinars
0:37
🛒🍎 The Good Food Prescription program from Good Measures combines expert clinical coaching, personalized meal planning and medically tailored grocery deliveries in partnership with Instacart. Read more to learn about the success of this program here: https://buff.ly/3OI5rTt | Xtalks Webinars
5 viewsFeb 14, 2024
FacebookXtalks Webinars
💡 🎙️ Tune in to the latest episode of the Xtalks Life Science Podcast featuring an enlightening conversation with Dr. Travaglia and Dr. Sethi as they delve into groundbreaking advancements in #ALS research and advocacy. Last month, the #FNIH launched the AMP #ALSresearch program to accelerate the discovery and development of treatments and diagnostics for ALS. This initiative aims to identify biomarkers and clinical outcome assessments for earlier diagnosis and faster drug development. 🎧 Watc
0:40
💡 🎙️ Tune in to the latest episode of the Xtalks Life Science Podcast featuring an enlightening conversation with Dr. Travaglia and Dr. Sethi as they delve into groundbreaking advancements in #ALS research and advocacy. Last month, the #FNIH launched the AMP #ALSresearch program to accelerate the discovery and development of treatments and diagnostics for ALS. This initiative aims to identify biomarkers and clinical outcome assessments for earlier diagnosis and faster drug development. 🎧 Watc
5 viewsJul 2, 2024
FacebookXtalks Webinars
🍹 Monster Beverage is making waves in the alcoholic beverage market with its latest creation: Nasty Beast Hard Tea. This brings a unique blend of tea and alcohol to the market, sans the caffeine typically found in Monster’s energy drinks. 🔋 Read more to learn about the new caffeine-free alcoholic beverage: https://buff.ly/3umFtxI #AlcoholicBeverages #MonsterBeverage #EnergyDrink #FoodTrends | Xtalks Webinars
0:37
🍹 Monster Beverage is making waves in the alcoholic beverage market with its latest creation: Nasty Beast Hard Tea. This brings a unique blend of tea and alcohol to the market, sans the caffeine typically found in Monster’s energy drinks. 🔋 Read more to learn about the new caffeine-free alcoholic beverage: https://buff.ly/3umFtxI #AlcoholicBeverages #MonsterBeverage #EnergyDrink #FoodTrends | Xtalks Webinars
8 viewsJan 30, 2024
FacebookXtalks Webinars
0:30
LIB Therapeutics has announced the FDA’s acceptance of its BLA for the investigational cholesterol-lowering drug lerodalcibep in a broad patient population. Read more at https://buff.ly/3WXu1ns by Ayesha Rashid about the drug, including its PDUFA target action date. | Xtalks Webinars
2 viewsFeb 13, 2025
FacebookXtalks Webinars
0:31
Metsera’s IPO introduces a novel class of therapies to the obesity landscape. Their NuSH analog peptides target new metabolic pathways, providing patients with potential alternatives to traditional weight-loss therapies. Learn more at https://buff.ly/418pTCz by Soumya Shashikumar. | Xtalks Webinars
1 viewsFeb 6, 2025
FacebookXtalks Webinars
0:47
💡 How is AI reshaping the future of medical writing? In this Xtalks Spotlight, Maria Hopfgarten, Head of Global Medical Writing at PPD Clinical Research, Thermo Fisher Scientific, explores how the integration of AI and human intelligence (HI) is creating new efficiencies. Learn about the challenges, opportunities, and the evolving role of medical writers in an AI-assisted environment, driven by advancements in natural language processing (NLP). Watch the full interview here: https://buff.ly/49y
10 viewsDec 19, 2024
FacebookXtalks Webinars
1:44
Seeking experienced life science professionals? Receive the best-qualified applicants today! Check out our newly launched job search platform and enjoy 3 free job posting credits: https://buff.ly/2QS7CFE #HR #recruitment #pharma #biotech #job | Xtalks Webinars
31 viewsSep 9, 2020
FacebookXtalks Webinars
0:31
Alcon’s Tryptyr (acoltremon ophthalmic solution) has won FDA approval for dry eye disease, offering a novel mechanism and quick relief for over 38 million US patients. Learn more about the disease and the drug by Soumya Shashikumar at https://buff.ly/ZVHRsOM. | Xtalks Webinars
83 views11 months ago
FacebookXtalks Webinars
1:26
🎧 Tune in to this Xtalks Life Science Podcast Episode where we interviewed Dr. Courtney Silverthorn who is an Associate Vice President at the Foundation for the National Institutes of Health (FNIH) and the Director of the Accelerating Medicines Partnership (AMP) program including the Bespoke Gene Therapy Consortium. 🌟 The FNIH recently announced that the AMP Bespoke Gene Therapy Consortium has selected eight rare diseases for its clinical trial portfolio. Xtalks spoke with Dr. Silverthorn abou
13 viewsJun 20, 2023
FacebookXtalks Webinars
0:33
Join Ana Fernandez-Ramos, PhD, Manuel Rodriguez, MD, and Mary Pevear for a webinar hosted by ICON about evidence-based strategies for site engagement that dramatically accelerate activation and enrollment. They will show how easing site burden can make you a partner of choice for high-performing sites, who often enroll twice as many patients in clinical trials. Register to gain global case studies and practical strategies for optimizing feasibility, training, and early protocol engagement: https
5 views6 months ago
FacebookXtalks Webinars
0:30
Ionis Pharmaceuticals will be sharing new trial data for its RNA-targeted prophylactic HAE treatment donidalorsen at the upcoming 2025 AAAAI/WAO Joint Congress in San Diego, California, where Ionis will have 11 presentations covering the data. Read more at https://buff.ly/41eIpcr by Ayesha Rashid. | Xtalks Webinars
6 viewsFeb 25, 2025
FacebookXtalks Webinars
0:30
Belgian AgeTech company Nobi has secured $37 million in an oversubscribed Series B funding round to advance its AI-powered smart lamp designed for fall detection and prevention among the elderly. Read more at https://buff.ly/40H2UxX by Ayesha Rashid. | Xtalks Webinars
4 viewsFeb 5, 2025
FacebookXtalks Webinars
0:30
Novartis’s newly approved Vanrafia (atrasentan) cut proteinuria by over 36% in a Phase III trial in patients with primary IgA nephropathy. Discover more about the once‑daily oral therapy in our latest article by Soumya Shashikumar at https://buff.ly/mCW3fqJ. | Xtalks Webinars
18 viewsApr 10, 2025
FacebookXtalks Webinars
0:30
The medtech industry faced major layoffs in 2024, driven by restructuring, profitability pressures and strategic pivots. Discover why companies like Philips, Medtronic and Illumina are realigning resources by Soumya Shashikumar at https://buff.ly/3CG9f4G. | Xtalks Webinars
23 viewsJan 29, 2025
FacebookXtalks Webinars
1:30
In this episode of the Xtalks Food Podcast, the team learns about the recent Trader Joe’s recalls. Also, hear about Netflix’s new food safety documentary, “Poisoned: The Dirty Truth About Your Food.” Listen now: https://buff.ly/47Ahdab #FoodPoisoning #FoodRecall #FoodPodcast | Xtalks Webinars
11 viewsAug 14, 2023
FacebookXtalks Webinars
0:31
Sling Therapeutics has announced positive results from a Phase IIb/III trial for its oral small-molecule therapy linsitinib for thyroid eye disease (TED). Read more at https://buff.ly/3WrZ0rH by Ayesha Rashid about the data and how the drug is set to rival Amgen’s Tepezza, the first and only approved TED drug on the market. | Xtalks Webinars
1 viewsJan 21, 2025
FacebookXtalks Webinars
0:30
Eli Lilly’s investigational siRNA therapy lepodisiran significantly reduced levels of a genetic heart disease risk factor in a Phase II trial. Read more at https://buff.ly/qOCn1Go by Ayesha Rashid about the results, and competitors like Novartis and Amgen who are developing similar therapies in the indication. | Xtalks Webinars
8 viewsApr 4, 2025
FacebookXtalks Webinars
0:36
In this episode, hear from Dr. Mario Marcondes, VP Head of Clinical Development at Nektar Therapeutics about novel immunotherapies for autoimmune disorders and cancer. Listen now at https://buff.ly/414nDgC 🎙️ | Xtalks Webinars
4 viewsFeb 6, 2025
FacebookXtalks Webinars
0:30
Beta Bionics has successfully raised $234.6 million from its IPO, which will fund the commercialization and clinical trials of its flagship product, the iLet bionic pancreas system. Learn more about the insulin dosing management system at https://buff.ly/3Qd3uPb by Soumya Shashikuma. | Xtalks Webinars
5 viewsFeb 11, 2025
FacebookXtalks Webinars
0:30
May 6 marks World Asthma Day, a global event spotlighting the over 260 million people worldwide living with asthma. Read more at https://buff.ly/I0vjZ2H by Ayesha Rashid about this year’s theme, “Make Inhaled Treatments Accessible for ALL,” which highlights the urgent need to ensure access to essential inhalers. | Xtalks Webinars
1 viewsMay 2, 2025
FacebookXtalks Webinars
1:44
In this episode of the Xtalks Food Podcast, the team learns about America’s first preservative-free salami. Also, hear about the controversial rise of water recipes from #WaterTok. Listen now: https://buff.ly/3P3rHbh #SocialMedia #FoodIndustry #FoodTrends #FoodPodcast | Xtalks Webinars
3 viewsJun 11, 2023
FacebookXtalks Webinars
0:30
Eli Lilly has cut prices on Zepbound vials and introduced higher-dose options. Read more at https://buff.ly/e5rAba6 by Ayesha Rashid on how this benefits patients paying out-of-pocket and those without obesity treatment coverage, while challenging competition from compounders. | Xtalks Webinars
13 viewsMar 5, 2025
FacebookXtalks Webinars
1:51
Hear this interview with Dr. Peter Sallstig, CMO of Santen Pharmaceuticals, which recently received approval for OMLONTI eye drops for the reduction of intraocular pressure. Listen now: https://buff.ly/3EjUB17 #EyeHealth #EyeDrops #VisionCare | Xtalks Webinars
16 viewsNov 11, 2022
FacebookXtalks Webinars
1:11
In this episode, Xtalks’ Editor-in-Chief Sarah Hand interviews Dr. Joshua Cohen, Chief Medical Officer at Braeburn about the approval of Brixadi for opioid use disorder (OUD) and explains the technology behind its extended-release formula. Listen now: https://buff.ly/3ObF9YT #OpioidUseDisorder #Buprenorphine #Braeburn #LifeSciencePodcast #Brixadi | Xtalks Webinars
30 viewsJul 13, 2023
FacebookXtalks Webinars
0:41
The Rett syndrome community received great news this year. The US Food and Drug Administration (FDA) approved Daybue (trofinetide), the first and only treatment for Rett syndrome. Read more here: https://buff.ly/42cAuKY #NeurologicalDisorder #RareDisease #GeneticDisorder #RettSyndrome | Xtalks Webinars
21 viewsMay 30, 2023
FacebookXtalks Webinars
0:30
Caris Life Sciences is building an AI-led diagnostics and oncology drug discovery engine — backed by $494M from its 2025 IPO. Our article by @soumya2390 at https://buff.ly/dHgVmrQ walks through the company’s tools, partnerships and where it's headed. | Xtalks Webinars
4 views11 months ago
FacebookXtalks Webinars
See more
Static thumbnail place holder